NOAH SARR: Open Payments
NPI 1114377686 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 84 payments from 20 companies in 2025. Trend: 2023 $3,009 · 2024 $1,247 · 2025 $1,749
Food & beverage: $1,749
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 27 | $363 |
| AstraZeneca Pharmaceuticals LP | 9 | $256 |
| ABBVIE INC. | 14 | $256 |
| E.R. Squibb & Sons, L.L.C. | 6 | $185 |
| Axsome Therapeutics, Inc. | 2 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Vanda Pharmaceuticals Inc. | 4 | $71 |
| Verity Pharmaceuticals Inc. | 3 | $57 |
| Lundbeck LLC | 2 | $51 |
Products named: CAPLYTA, COBENFY, VRAYLAR, BREZTRI, REXULTI, Auvelity, AIRSUPRA, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
